Search Results - "Churg, Andrew M."

Refine Results
  1. 1
  2. 2

    Usefulness of methylthioadenosine phosphorylase and BRCA‐associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens by Berg, Kyra B., Churg, Andrew M., Cheung, Simon, Dacic, Sanja

    Published in Cancer cytopathology (01-02-2020)
    “…Background The separation of benign from malignant mesothelial proliferations on effusion cytology can be difficult. Loss of methylthioadenosine phosphorylase…”
    Get full text
    Journal Article
  3. 3

    Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases by Dvorak, Leah A., MD, Vassallo, Robert, MD, Kirmani, Salman, MBBS, Johnson, Geoffrey, MD, PhD, Hartman, Thomas E., MD, Tazelaar, Henry D., MD, Leslie, Kevin O., MD, Colby, Thomas V., MD, Cockcroft, Donald W., MD, Churg, Andrew M., MD, Yi, Eunhee S., MD

    Published in Human pathology (01-01-2015)
    “…Summary Dyskeratosis congenita (DC) is a disorder of poor telomere maintenance and is related to 1 or more mutations that involve the vertebrate telomerase RNA…”
    Get full text
    Journal Article
  4. 4

    Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma by Chiu, Kenrry, Lee, Lawrence, Cheung, Simon, Churg, Andrew M.

    Published in Modern pathology (01-09-2018)
    “…Immunohistochemistry (IHC) is used to help differentiate pleural mesothelioma from pulmonary adenocarcinoma in pleural biopsies and cytology specimens of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Does Compromised Immune Exclusion Drive Inflammatory Processes in Chronic Obstructive Pulmonary Disease? by Stampfli, Martin R, Churg, Andrew M

    “…A complex and multilayered immune defense system, consisting of physical barriers and innate and adaptive immune mechanisms, protects the lungs from harmful…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Statin Reverses Smoke-induced Pulmonary Hypertension and Prevents Emphysema but Not Airway Remodeling by WRIGHT, Joanne L, ZHOU, Steven, PREOBRAZHENSKA, Olena, MARSHALL, Caroline, SIN, Don D, LAHER, Ismail, GOLBIDI, Saeid, CHURG, Andrew M

    “…the potential role of statins in treating chronic obstructive pulmonary disease (COPD) is controversial, and it is unclear what anatomic COPD lesions statins…”
    Get full text
    Journal Article
  9. 9

    Localized malignant mesothelioma by ALLEN, Timothy Craig, CAGLE, Philip T, TRAVIS, William D, WICK, Mark R, CHURG, Andrew M, COLBY, Thomas V, GIBBS, Allen R, HAMMAR, Samuel P, CORSON, Joseph M, GRIMES, Margaret M, ORDONEZ, A Nelson G, ROGGLI, Victor

    Published in The American journal of surgical pathology (01-07-2005)
    “…Localized malignant mesotheliomas are uncommon sharply circumscribed tumors of the serosal membranes with the microscopic appearance of diffuse malignant…”
    Get full text
    Journal Article
  10. 10

    Malignant pleural mesothelioma: Computed tomography and correlation with histology by Seely, Jean M, Nguyen, Elsie T, Churg, Andrew M, Müller, Nestor L

    Published in European journal of radiology (01-06-2009)
    “…Abstract Objective To review the computed tomography (CT) imaging findings of pleural mesothelioma at presentation and to correlate the CT with the…”
    Get full text
    Journal Article
  11. 11

    Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma by Leung, Stefanie C., Churg, Andrew M., Leipsic, Jonathon A., Levy, Robert D., Wilcox, Pearce G., Ryerson, Christopher J.

    Published in Respirology case reports (01-09-2015)
    “…Interstitial lung disease (ILD) classification requires a multidisciplinary review that includes input from an ILD clinician, chest radiologist, and lung…”
    Get full text
    Journal Article
  12. 12

    Pleural nodular mesothelial/histiocytic hyperplasia associated with syphilis by Berg, Kyra B., MD, Liebling, Peter D., MD, Kubik, Melanie J., MD, Attanoos, Richard, MD, Galateau-Salle, Francoise, MD, Roggli, Victor, MD, Wick, Mark, MD, Churg, Andrew M., MD

    Published in Human pathology : case reports (01-09-2018)
    “…AbstractNodular mesothelial/histiocytic hyperplasia (NMHH) is a benign reactive phenomenon that can occur at any mesothelial site. We report the case of a…”
    Get full text
    Journal Article
  13. 13

    Pleural amyloidosis imitating pleural malignancy by Coolbear, Frith, MBChB, Bilawich, Ana-Maria, MD, Tongson, Jonathan, MD, Adamo, James, MD, Churg, Andrew, MD

    Published in Respiratory medicine case reports (01-01-2017)
    “…Abstract CT chest performed to investigate dyspnea and malaise in an 83 year old man demonstrated bilateral circumferential pleural thickening highly…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Loss of BRCA1-associated Protein 1 ( BAP1 ) Expression Is Rare in Non-Small Cell Lung Cancer by Owen, Daniel, MD, Sheffield, Brandon S., MD, Ionescu, Diana, MD, Churg, Andrew, MD

    Published in Human pathology (01-02-2017)
    “…Summary BRCA1-associated protein 1 ( BAP1 ) is a tumor suppressor gene involved in regulation of the cell cycle, cellular differentiation, repair of DNA damage…”
    Get full text
    Journal Article
  16. 16

    Unclassifiable interstitial lung disease by Leung, Stefanie C, Churg, Andrew M, Leipsic, Jonathon A, Levy, Robert D, Wilcox, Pearce G, Ryerson, Christopher J

    Published in Respirology case reports (01-09-2015)
    “…Interstitial lung disease (ILD) classification requires a multidisciplinary review that includes input from an ILD clinician, chest radiologist, and lung…”
    Get full text
    Journal Article
  17. 17

    Accuracy of classifying poorly differentiated non–small cell lung carcinoma biopsies with commonly used lung carcinoma markers by Zachara-Szczakowski, Susanna, MD, Verdun, Tyler, MD, Churg, Andrew, MD

    Published in Human pathology (01-05-2015)
    “…Summary Immunohistochemical (IHC) staining is an important adjunct to the classification of non–small cell lung carcinoma (NSCLC). Several studies have used…”
    Get full text
    Journal Article
  18. 18

    Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report by MacLean, Alyssa, Churg, Andrew, Johnson, Scott Thomas

    Published in JTO clinical and research reports (01-08-2022)
    “…Mesothelioma in situ is a recently described precursor to invasive mesothelioma. Thus far, all cases in the literature have involved one pleural cavity or the…”
    Get full text
    Journal Article
  19. 19

    The Complex Relationship of Serum Adiponectin to COPD Outcomes by Yoon, Ho Il, MD, PhD, Li, Yuexin, MD, Man, S.F. Paul, MD, FCCP, Tashkin, Donald, MD, Wise, Robert A., MD, FCCP, Connett, John E., PhD, Anthonisen, Nicholas A., MD, PhD, Churg, Andrew, MD, Wright, Joanne L., MD, Sin, Don D., MD, FCCP

    Published in Chest (01-10-2012)
    “…Background COPD is a chronic inflammatory disorder with high risk of cardiovascular morbidity and mortality. Adiponectin is a hormone that has…”
    Get full text
    Journal Article
  20. 20

    Pulmonary Alveolar Proteinosis as a Reaction to Fentanyl Patch Smoke by Chapman, Erin, MD, Leipsic, Jonathon, MD, Satkunam, Niranjala, MD, Churg, Andrew, MD

    Published in Chest (01-05-2012)
    “…We report a patient who developed shortness of breath and systemic symptoms after starting to smoke fentanyl patches. CT scan showed ground glass centrilobular…”
    Get full text
    Journal Article